17/07/2024
I am so happy that I have co-founded with my friend and colleague Prof. Dr. Ari Zimran the innovative and creative company Agyany Pharma Ltd; together we are focusing on the development of disease modification and prevention of GBA1-related Parkinson disease (PD), which differs from the common idiopathic PD by presenting at a younger age and a more progressive clinical course. Agyany Pharma Ltd adresses the highly promising concept of pharmacological chaperons. I am thrilled to have great friends and colleagues on board, like Noel Mueller (CFO), Jonathan Arnon (Legal), Majdolen Istaiti (Clinical Operations), Dr. Volha Skrahina (Regulatory), Dr. Jan Lukas (Drug Development), Doreen Niemann (Operations), !
